Neurotoxic effects associated with antibiotic use: management considerations
about
Dysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal NeuropathyAntibiotic stewardship in the intensive care unit.Tremors and agitation following low-dose intravenous hydromorphone administration in a patient with kidney dysfunction.Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis.Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia IsolatesComparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Nonconvulsive status epilepticus cases arising in connection with cephalosporins.Possible ameliorative effects of antioxidants on propionic acid / clindamycin - induced neurotoxicity in Syrian hamsters.Gut dysbiosis impairs recovery after spinal cord injury.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Improving the prediction of drug disposition in the brain.Update on management of patients with overt hepatic encephalopathy.Antibiotic-induced neurotoxicity.Safety issues and drug-drug interactions with commonly used quinolones.Predominant Jaw Myoclonus from Cefepime Toxicity: A Case Report and a Review of the LiteraturePattern of Use of Antibiotics Following Snake Bite in a Tertiary Care HospitalNeurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review.Neurologic Complications of Commonly Used Drugs in the Hospital Setting.Gut microbiota impact on stroke outcome: Fad or fact?Emerging pollutant treatments in wastewater: Cases of antibiotics and hormones.Neuropsychiatric Effects of Antimicrobial Agents.Predicting neurological Adverse Drug Reactions based on biological, chemical and phenotypic properties of drugs using machine learning models.Infections in Neurocritical Care.Metronidazole-Induced Cerebellar Toxicity.Comparison of the effects of cefazolin and ceftriaxone on canine chondrocyte culture.The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme.Probable Nonconvulsive Status Epilepticus With the Use of High-Dose Continuous Infusion Ceftazidime.Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication.Myoclonic status epilepticus in six patients without epilepsy.Negative Myoclonus Induced by Ciprofloxacin.Ertapenem-Induced Encephalopathy in a Patient With Normal Renal FunctionNot all β-lactams are equal regarding neurotoxicitySimultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet DetCerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats.Antibiotic-induced neurotoxicity in dialysis patients: a retrospective study.Phytochemical screening and in vitro antimicrobial activity of Thymus lanceolatus Desf. from Algeria.Orofacial dyskinesia associated with the use of levofloxacin.Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
P2860
Q28066841-08051965-AE19-4379-A885-D01129FDA89BQ28116186-29323031-81CD-450A-ADE0-6E54CE2E1C8BQ30408712-401B262A-7BC4-403E-9135-F3684379FC44Q34347201-9E02F22F-744D-4163-A70E-798CC85A5DA0Q35015788-28786179-9DBB-45AC-A1EA-7321C2E030F2Q35661664-BD0E962F-8F9F-4B59-85BB-E7BFDDDBB349Q36087129-C88B0326-263C-4530-933F-D702004FDCB1Q36287127-715B2FEC-0C7C-44C6-BC62-261292174A16Q37049192-813536EA-203E-4A26-A490-02173A0BC490Q37309388-9626A4E2-5115-4E36-B1B3-66E405239854Q37415195-E30F4C59-A260-448D-8FFB-6BF2DE19B7C2Q38004063-440B32AC-060B-468C-AE8E-346F42FF8656Q38072077-04A61230-8CEF-480A-BF37-047BC5F01053Q38129187-19F14A16-3A25-4E10-9641-EDA385F9F8F7Q38263096-8F5574BC-157C-4EAA-9B2B-C7742C52FE96Q38271318-D2050869-C7AC-4CC1-BE42-B4EA982A7623Q38594298-BEB351D3-B37A-4EDB-8C62-1196D1160683Q38599070-6551E155-FE58-495E-8680-38EF6A24D7EFQ38654209-61A5CAD4-1101-4B2F-8DD1-BA53559009F3Q38746169-AD942641-C5EA-467D-95A1-AA66F07B0C40Q38761518-660F5D83-4832-4F63-A41A-D775717CE545Q39024501-B1745D4E-4BFC-40EE-8AA1-9473C3425EF4Q39135986-7F602674-0FC8-45E0-85C0-6E4074904A09Q39157047-F023A914-00EE-4338-921E-D7F0D40D82FEQ39389836-730FCEF1-225B-4D3B-B174-94F4042E0C7BQ40128360-6B185A9E-4D24-4E3B-B0FA-D469A33412DBQ40288762-83A39533-C8C7-4C41-B48E-87C4866C32EBQ40907461-BF22898F-41B1-4A72-A4C4-A2F78E230BC4Q40948470-B491C6A4-B70A-4CE1-8F16-CA0F19C9FDAAQ41033465-9CF20BAC-03BD-4DC3-BA31-5B065D23C548Q41423059-6F927A79-FBFF-4E49-8F5E-A427D512F403Q42288598-D2FADD98-FBD7-49F2-870F-9E6C939B5906Q42323100-B5A7F182-7B91-472B-991C-B8755D1C5AFDQ42379657-A127AF98-36D7-4033-87A4-A5004C55E847Q42407649-F5F4F787-2513-4A29-91C3-4E511F4083B9Q42716996-40B687F3-5161-4F90-A28C-2CFA5A949317Q43870295-28C80131-8FB3-4604-94FD-5960FDDE32BAQ46000263-DC48FDA1-CE6F-4412-B6BA-B4059E9543D0Q46064422-CEE9DF86-D83A-42DD-ADB2-3E7FAF6A21B8Q47677698-B52357B3-97B6-4CB3-A43E-916307C88222
P2860
Neurotoxic effects associated with antibiotic use: management considerations
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Neurotoxic effects associated with antibiotic use: management considerations
@ast
Neurotoxic effects associated with antibiotic use: management considerations
@en
type
label
Neurotoxic effects associated with antibiotic use: management considerations
@ast
Neurotoxic effects associated with antibiotic use: management considerations
@en
prefLabel
Neurotoxic effects associated with antibiotic use: management considerations
@ast
Neurotoxic effects associated with antibiotic use: management considerations
@en
P2860
P1476
Neurotoxic effects associated with antibiotic use: management considerations
@en
P2093
Marie F Grill
Rama K Maganti
P2860
P304
P356
10.1111/J.1365-2125.2011.03991.X
P407
P577
2011-09-01T00:00:00Z